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Abstract 
Antimicrobial resistance has been reported to represent a growing threat to 
both human and animal health, and concerns have been raised around levels 
of antimicrobial usage (AMU) within the livestock industry. To provide a 
benchmark for dairy cattle AMU and identify factors associated with high 
AMU, data from a convenience sample of 358 dairy farms were analysed 
using both mass-based and dose-based metrics following standard 
methodologies proposed by the European Surveillance of Veterinary 
Antimicrobial Consumption project. Metrics calculated were mass (mg) of 
antimicrobial active ingredient per population correction unit (mg/PCU), 
defined daily doses (DDDvet) and defined course doses (DCDvet). AMU on 
dairy farms ranged from 0.36 to 97.79 mg/PCU, with a median and mean of 
15.97 and 20.62 mg/PCU, respectively. Dose-based analysis ranged from 
0.05 to 20.29 DDDvet, with a median and mean of 4.03 and 4.60 DDDvet, 
respectively. Multivariable analysis highlighted that usage of antibiotics via 
oral and footbath routes increased the odds of a farm being in the top quartile 
(>27.9 mg/PCU) of antimicrobial users. While dairy cattle farm AMU appeared 
to be lower than UK livestock average, there were a selection of outlying 
farms with extremely high AMU, with the top 25 per cent of farms contributing 
greater than 50 per cent of AMU by mass. Identification of these high use 
farms may enable targeted AMU reduction strategies and facilitate a 
significant reduction in overall dairy cattle AMU. 
http://dx.doi.org/10.1136/vr.104614 
  
Introduction 
Antimicrobial resistance (AMR) has been reported to represent a growing 
threat to both human and animal health,1 with the inappropriate use of 
antimicrobials in human and animal fields being considered responsible for the 
emergence of resistance in bacteria.2 Concerns have been raised regarding 
the zoonotic transfer of resistant bacteria from livestock to 
human beings,3 with potential routes of transfer including food 
products,4 direct contact5 and via environmental contamination.6 There are 
however many knowledge gaps in livestock–human AMR transfer routes,7 and 
links between on-farm antimicrobial usage (AMU) and the increased transfer 
of major foodborne drug-resistant organisms such as Campylobacter spp 
and Salmonella spp have not been found.8 9 
Remarkably strong interactions between AMU and AMR in livestock have 
been described,10 and UK Government-commissioned reports have called for 
a reduction in antimicrobial use within the livestock industry.11 There are 
numerous metrics available to measure veterinary AMU, which have great 
impact on both the AMU figures obtained and consequent influence on AMU 
reduction policy,12 and international recommendations have been provided for 
the most suitable metrics to monitor both human and veterinary AMU.13 The 
UK Government has called for an AMU reduction target from 62 mg per 
population correction unit (mg/PCU) in 2013 to less than 50 mg/PCU as an 
average across all livestock sectors by 2018,14 and total livestock AMU figures 
for the UK indicate this target has already been reached.15 Farm-level AMU 
monitoring studies in dairy cattle have been conducted in several countries 
including the USA,16 Canada,17 New Zealand18 and the Netherlands19; 
however, to date, no detailed farm-level AMU studies identifying factors 
associated with high AMU have been conducted in the UK dairy industry. 
Therefore, this study aims to provide an evaluation of the levels of AMU in a 
convenience sample of British dairy farms over a 12-month period and to 
identify factors associated with high usage on these farms. 
Methods 
Sources of data 
Data were collected from both veterinary practice records and electronic on-
farm records between January 1, 2016 and December 31, 2016. A 
convenience sample of four farm animal veterinary practices in the south, 
midlands and north of England was identified after an expression of interest in 
AMU monitoring, and anonymised antimicrobial sales data were provided for 
all dairy farm clients between January 1, 2016 and December 31, 2016. Cow 
numbers were estimated for each farm using electronic cattle movement 
records (using the British Cattle Movement Service Cattle Tracing System, 
with animals being >24 months and female) for two practices or otherwise 
directly from farmer estimates of average adult dairy cow numbers. Farms 
with any other livestock on farm (ie, sheep or beef enterprises) were excluded 
from the study to ensure antimicrobials purchased were solely for dairy cattle. 
AMU records were obtained from a separate group of farms recording 
medicines usage electronically on farm, which were enrolled in regular milk 
recording with a laboratory based in the south of England (Quality Milk 
Management Services). Farmer-recorded electronic medicines records, cow 
numbers and veterinary practice ID were extracted from on-farm software. 
Antimicrobial sales records were collected for 332 farms, with 40 farms being 
excluded due to the presence of a livestock enterprise other than dairy, 
resulting in a final data set of 292 farms. Electronically recorded AMU records 
were collected from 70 farms, with 4 farms being excluded due to data 
recording errors, resulting in a final data set of 66 farms. These two data sets 
were combined to provide a total of 358 farms, with antimicrobial data for 
81,640 dairy cows (Table 1), representing ~3.6 per cent of total dairy farms 
and ~7.0 per cent of total dairy cows in England.20 Farm size ranged from 21 
to 2080, with a mean herd size of 228. The four practices supplying 
antimicrobial sales data were dominated by one practice providing information 
for 182 farms, with the other three practices supplying data for the remaining 
110 farms (Table 1). 
 
Practice 1 Practice 2 Practice 3 Practice 4 All Sales All Use All farms 
Min 70 37 21 25 21 50 21 
Max 340 550 562 2080 2080 1290 2080 
Median 160 120 199 179 171 183 172 
Mean 178 160 199 252 223 249 228 
Total dairy cows 3551 8807 6973 45892 65223 16417 81640 
Total dairy farms 20 55 35 182 292 66 358 
TABLE 1: Cow numbers per farm for four veterinary practices that provided antimicrobial 
sales data (‘All Sales’) and from a group of farms recording medicines usage electronically 
(‘All Use’) 
 
Calculation of AMU 
Total mass (mg) of antimicrobial active ingredient per population correction 
unit (mg/PCU) was calculated using the European Surveillance of Veterinary 
Antimicrobial Consumption (ESVAC) standard methodology,21 using a 
standardised adult dairy cow bodyweight of 425 kg. Youngstock and 
slaughtered animals were not included in the calculation of PCU, and topical 
sprays were not included in the calculation of antibiotic mass. 
To facilitate comparison between different monitoring metrics, three separate 
metrics were calculated for both sales and usage data: mg/PCU, defined daily 
doses (DDDvet) and defined course doses (DCDvet). Critically important 
antibiotics (CIAs) were defined as third-generation or fourth-generation 
cephalosporins and fluoroquinolones.22 
DDDvet calculations followed standard ESVAC/European Medicines Agency 
(EMA) methodology21 to provide an estimation of AMU while taking into 
account differences in dosing between antimicrobial products. Oral and 
parenteral antibiotic formulations were calculated per kilogram of animal (adult 
dairy cow weight being 425 kg), and intrauterine and lactating cow 
intramammary doses (IMM) were calculated per cow. Antibiotic dry cow 
therapy (DCT) was excluded from DDDvet calculations as per ESVAC/EMA 
methodology, as were topical antibiotic therapies (including antibiotic 
footbathing). 
DCDvet calculations were performed similarly, calculating oral and parenteral 
doses per kilogram, intrauterine and lactating cow intramammary courses per 
cow, also including dry cow intramammary therapy, with four tubes per cow 
being equal to a single course. 
Basic descriptive statistics (range, median, mean) were performed for all 
metrics calculated, and total mass of antimicrobials by route was also 
calculated and illustrated graphically. Calculations were repeated for CIAs. 
Total AMU/sales per farm were graphically illustrated for each practice to 
identify any patterns within practices. This was also repeated for CIAs. Basic 
descriptive statistics and graphical illustrations were conducted using 
Microsoft Excel 2016 and R V.3.4.0 statistical software.23 
Statistical analysis 
To investigate factors that influenced farms being high antimicrobial users, 
multilevel logistic regression models were developed using MLwiN,24 with 
farms in the top 25 per cent of antimicrobial users 
(>27.9 mg/PCU, >5.88 DDDvet or >2.32 DCDvet) as a binary outcome variable 
(highest 25 per cent or not). Categorical variables were created for herd size 
(small <136, medium 136–236, large >236), and a binary variable of route 
usage was created illustrating either ‘used’ or ‘did not use’ for each route 
category (parenteral, IMM, DCT, footbath, intrauterine, oral, pessary). Models 
were constructed using a backwards stepwise approach until variables that 
remained in the model were significant at  P < 0.05, and model fit was 
checked using a modified Hosmer-Lemeshow method25. A multilevel structure 
was employed to allow for correlations between farms within veterinary 
practices, with veterinary practice being included as a random effect. 
Parameters were estimated using iterative generalised least squares. Final 
parameter estimates were generated using Markov Chain Monte Carlo 
(MCMC), with Gibbs sampling to avoid potential parameter bias.26 A burn in 
chain of 500 iterations with a monitoring chain of 10,000 iterations was used, 
and MCMC chains were visually checked to ensure convergence. To estimate 
the proportional reduction in high AMU farms that would occur if significant 
risk factors were removed, population attributable fractions (PAFs) were 
calculated for significant model covariates.27 PAFs and 95 per cent confidence 
intervals were calculated directly from MCMC chains using R statistical 
software (R V.3.4.0 2017). 
Results 
Antimicrobial sales to dairy farms ranged from 0.36 to 97.79 mg/PCU, with a 
median and mean of 17.25 and 22.11 mg/PCU, respectively. DDDvet for sales 
data ranged from 0.05 to 20.29 doses, with a median and mean of 4.22 and 
4.84, respectively. DCDvet for sales data ranged from 0.01 to 6.74 courses, 
with a median and mean of 1.73 and 1.93, respectively. 
Farmer-recorded AMU ranged from 1.20 to 48.48 mg/PCU, with a median and 
mean of 11.42 and 14.06 mg/PCU, respectively. DDDvet for usage data 
ranged from 0.14 to 16.09 doses, with a median and mean of 3.24 and 3.56, 
respectively, and DCDvet for usage data ranged from 0.33 to 5.33 courses, 
with a median and mean of 1.55 and 1.58, respectively. 
Of all the farms included in this study, the median AMU was 15.97 mg/PCU, or 
4.03 DDDvet and 1.69 DCDvet. The mean AMU from all the farms in the study 
was 20.62 mg/PCU, or 4.60 DDDvet and 1.86 DCDvet (Table 2). 
  
 
  
Source (Farm numbers) 
  
Practice 
1 (20) 
Practice 
2 (55) 
Practice 
3 (35) 
Practice 
4 (182) 
All 
Sales 
(292) 
All 
Use 
(66) 
All 
farms 
(358) 
mg/PCU Min 7.84 0.36 5.02 0.55 0.36 1.20 0.36 
 
Max 85.92 97.79 96.47 70.76 97.79 48.48 97.79 
 
Median 19.86 18.62 32.41 15.55 17.25 11.42 15.97 
 
Mean 26.85 22.59 38.07 18.37 22.11 14.06 20.62 
         
DDDvet Min 0.90 0.07 0.97 0.05 0.05 0.14 0.05 
 
Max 17.23 18.59 12.78 20.29 20.29 16.09 20.29 
 
Median 6.39 5.01 4.89 3.71 4.22 3.24 4.03 
 
Mean 6.48 6.04 5.57 4.15 4.84 3.56 4.60 
         
DCDvet Min 0.26 0.02 0.31 0.01 0.01 0.33 0.01 
 
Max 6.62 6.74 4.45 6.63 6.74 5.33 6.74 
 
Median 2.35 2.23 1.81 1.57 1.73 1.55 1.69 
 
Mean 2.61 2.45 2.09 1.67 1.93 1.58 1.86 
TABLE 2: 
Antimicrobial usage (mg/PCU, DDDvet, DCDvet) for four veterinary practices that provided 
antimicrobial sales data (‘All Sales’) and from a group of farms recording medicines usage 
electronically (‘All Use’) 
Antibiotic sales and usage largely consisted of injectable treatments, 
comprising 78.1 per cent of total antibiotic mass used or sold (Fig 1). Lactating 
cow intramammary treatments represented 6.5 per cent of antimicrobial active 
ingredient mass (mg), with DCT representing 6.0 per cent. Off-licence 
antibiotic footbath powders represented 4.5 per cent of total mg, and oral 
powders, intrauterine treatments and pessaries combined represented 
5.0 per cent. Beta lactams made up the bulk of antimicrobials, totalling 
42.8 per cent of mg, with aminoglycosides totalling 20.9 per cent. CIAs totalled 
3.3 per cent of mg, with third-generation or fourth-generation cephalosporins 
and fluoroquinolones comprising 2.5 per cent and 0.8 per cent of mg, 
respectively, and representing a mean farm AMU of 4.7 per cent of mg/PCU 
ranging from 0 to 47.6 per cent. Due to the relatively lower dosing 
requirements of CIAs, CIAs represented a higher proportion of doses 
administered, ranging from 0 to 90.1 per cent DDDvet and from 0 to 89.0 per 
cent DCDvet, representing a mean of 17.8 per cent DDDvet and 14.9 per cent 
DCDvet, respectively. 
 
FIG 1: Total mass (kg) of antimicrobial classes from sales data to farms (n=292) from four 
veterinary practices and for usage data from farms (n=66) recording medicines usage 
electronically on farm. DCT, dry cow therapy; IMM, intramammary lactating cow therapy. 
 
The majority of farms used/purchased antibiotic IMM and DCT products (345 
(96 per cent) and 338 (94 per cent), respectively), and all farms 
used/purchased injectable antibiotic products. Farms also used/purchased the 
following products: intrauterine antibiotics (184 (51 per cent)), antibiotic 
pessaries (117 (33 per cent)), antibiotic footbaths (98 (27 per cent)) and oral 
antibiotics (18 (5 per cent)). Multivariable regression modelling illustrated that 
the use of oral and footbath antibiotics significantly increased the odds of a 
farm being in the top 25 per cent of antimicrobial users, measured by mg/PCU 
(Table 3). Other variables such as herd size and usage of other routes of 
antimicrobial administration (parenteral, IMM, DCT, intrauterine and pessary) 
did not remain in the model. 
 
  
 
Outcome variable Explanatory variable 
(N) 
Odds 
ratio 
95%CI P-
value 
Population 
attributable 
fraction (%)  
95%CI 
Top 25% AMU 
(mg/PCU) (n=90) 
Oral antibiotics used 
(n=13) 
9.43 (2.76-32.27) <0.001 8.4 (3.03-14.00) 
Antibiotic footbath 
used (n=39) 
2.75 (1.46-5.17) 0.001 20.28 (8.99-33.02) 
 
TABLE 3: Logistic regression model of factors affecting the odds of farms (n=358) being in 
the highest 25 per cent of antimicrobial users (as measured by mg/PCU) 
Discussion 
Given that cattle represents 25 per cent of total livestock mass in the UK as 
estimated by PCU,15 roughly equivalent to pig and poultry PCU combined, 
AMU within the cattle industry plays an important role in the UK’s overall AMU. 
The results from this study indicate that AMU in dairy cattle is likely to be 
significantly lower than overall UK livestock AMU of 45 mg/PCU in 
2016.15 While a large proportion of dairy farms are likely to be relatively low in 
terms of AMU, in this data set there exists an outlying population of farms that 
exhibit a relatively high usage of antimicrobials, with the highest 25 per cent of 
antimicrobial users representing 52 per cent of the total mass (mg) of 
antimicrobials. Establishing monitoring methods and targets will be essential 
to identify high antimicrobial users, and an understanding of factors that 
influence relatively high AMU will allow targeted AMU reduction interventions. 
Injectable preparations represented the majority of antimicrobial use/sales 
mass, with the remainder being predominantly IMM, DCT and footbath routes 
(Fig 1). Of injectable products 3.5 per cent by mass were CIAs, and injectable 
treatments largely comprised beta lactams (40.6 per cent) and 
aminoglycosides (22.1 per cent) by mass, representing the common usage of 
both penicillin-based antibiotics and penicillin streptomycin combinations. 
Differences between monitoring metrics resulted in important differences 
between proportions of AMU attributed to various routes of therapeutic 
application, which has the potential to influence national-level and farm-level 
protocols to reduce AMU. Mass-based AMU monitoring (ie, mg/PCU) appears 
heavily influenced by parenteral therapy, potentially incentivising the reduction 
of parenteral therapy as a priority with IMM treatments playing a small role in 
overall mg/PCU as previously reported.12 Dose-based metrics (ie, DDDvet, 
DCDvet), however, highlight IMM therapies as major contributors to total AMU 
and may encourage reductions in IMM antimicrobials as a priority. While there 
is a degree of correlation between the monitoring methodologies, there are 
high AMU farms that would not be detected if a single monitoring metric was 
used (Fig 2), with high IMM and high footbath AMU being particularly poorly 
represented when using mass-based or dose-based methodology, 
respectively. Given that monitoring methodologies will potentially incentivise 
reductions in specific treatment routes, it may be prudent to aim for AMU 
reductions as monitored by both mass-based and dose-based metrics. 
 
FIG 2: Antimicrobial usage measured by mg/PCU compared with DDDvet (blue) and DCDvet 
(orange) from sales data to farms from four veterinary practices and for usage data from 
farms recording medicines usage electronically. The total number of farms is 
358. DCDvet, defined course doses; DDDvet, defined daily doses; PCU, population 
correction unit.  
 
The reduction/cessation of usage of antibiotics critically important for human 
health has received great attention within the livestock industry.11 The current 
study demonstrated that CIAs represent a mean of 4.7 per cent mg/PCU used 
on dairy farms, which is high compared with other species (1 per cent of all 
livestock mg/PCU in 201615). When employing dose-based methodology, 
the mean farm CIA usage represented 17.8 per cent of DDDvet and 
14.9 per cent of DCDvet, respectively, a difference largely due to generally 
lower dosing requirements of CIAs. Since pressure on the livestock industry to 
reduce CIA usage will continue to grow, the usage of CIAs on dairy farms will 
come under scrutiny. To reduce AMU across the livestock industry, it will be 
important to provide industry-specific targets both in terms of reducing overall 
usage and specific therapeutics such as CIAs. 
Monitoring dairy farm AMU to identify high antimicrobial users would enable 
targeted interventions to facilitate the most effective reductions in overall 
AMU. The use of oral and footbath antibiotics on farms appears to increase 
the odds of farms being in the highest 25 per cent of antimicrobial users 
(mg/PCU), possibly indicating the effects of group medication protocols on 
increased AMU. This study also illustrated that while most dairy cattle farms 
do not employ these methods of medication, those that do can dramatically 
increase overall mass-based AMU (Fig 3). High levels of injectable antibiotic 
usage are also likely to be a significant driver of overall AMU as measured by 
mg/PCU, but due to all farms using injectable products, injectable usage was 
not retained in the final multivariable model. Targeting the reduction of AMU 
among the minority of high antimicrobial users while maintaining high 
standards of health, welfare and production may be a fast and effective first 
step to reduce AMU at farm, practice and national levels. 
 
FIG 3: Antimicrobial usage (mg/PCU) by route from sales data to farms from four veterinary 
practices and for usage data from farms recording medicines usage electronically. Points 
represent antimicrobial usage (mg/PCU) for each farm by route, with box plots illustrating 
interquartile range and median. The total number of farms is 358. DCT, dry cow therapy; 
IMM, intramammary lactating cow; PCU, population correction unit.  
 
UK legislation requires medicines administered to livestock to be recorded on 
farm and the sales of all veterinary products to livestock businesses to be 
recorded by veterinary practices,28 resulting in two readily available data 
sources for farm-level AMU monitoring. Farmer-recorded usage will potentially 
under-report actual usage on farm, as farmer-inputted medicines use has 
previously been shown to be an under-representation when compared with 
medicines sales.19 29 This may in part be related to medicines being bought in 
bulk and not all being used (and therefore not recorded), alongside errors in 
updating medicines records. In contrast, practice sales records capture all 
antimicrobials sold to a farm, and therefore may over-report AMU due to 
antimicrobials not ultimately used. Since important differences in recording 
methodology and terminology exist between both farms and practices, 
standardisation of recording protocol will be essential in national monitoring 
efforts, and caution should be taken when comparing farmer-recorded usage 
with antimicrobial sales figures. 
AMU comparisons between monitoring studies can be challenging, with many 
factors influencing both the numerator (mg or doses) and the denominator 
(PCU) populations, depending on methodology used. The standard weight of 
an adult cow will have a significant bearing on denominator population, with 
studies using ‘weight at time of treatment’ such as 425 kg21 potentially 
underestimating weight when compared with live cattle weights such as 
600 kg17 19 and 680 kg,16 resulting in AMU overestimation. The 
inclusion/exclusion of youngstock also has bearing on the denominator 
population, and the inclusion of youngstock AMU in this study despite 
exclusion of youngstock PCU may slightly overestimate AMU as previously 
described,17 19although AMU for calves have previously been reported to likely 
represent a small proportion of total AMU on dairy farms.19 DCT recording, 
however, can have a significant bearing on dose-based methodologies, and 
while DCT is excluded from DDDvet,21 doses both per cow and per teat have 
been previously reported.17 19 Antibiotic footbathing has a dramatic effect on 
mg/PCU, however is not accounted for when applying DDDvet or DCDvet 
methodologies. It is challenging to provide clear guidance as to the ‘dosage’ 
applied to each animal, and anecdotally ~100 g of antibiotic powder might be 
advised to treat around 100 cows via footbath. Using a dosage of 1 g of 
product per cow as a daily dose allows an estimation into the effect of 
footbathing on the dose-based metrics, which would increase mean farm AMU 
by over 10 per cent from 4.6 to 5.1 DDDvet. 
ESVAC/EMA calculations based on live dairy cattle and slaughter weights 
have been largely designed to facilitate national/international monitoring, and 
are not intended for farm-level comparisons. Since the number of youngstock 
on dairy farms varies widely, it can be challenging to directly compare farms 
due to the variation in PCU not captured using ESVAC/EMA methodology. 
Cattle births, deaths and movements in the UK are reported to the British 
Cattle Movement Service.30 Using this database, it should be possible to 
identify a relatively accurate estimation of PCU present on each holding by 
assigning weights to each age category, calculating number of days spent in 
each weight class and providing an overall estimation as to kg/year at risk. 
This methodology should reduce PCU estimation errors between dairy farms 
with variations in youngstock rearing and would also be applicable to the beef 
industry, where a wide range of farm management systems make farm-level 
AMU comparisons challenging. 
The mean herd size (228) in this study was larger than average for dairy herds 
in England (14520), although herd size did not appear to be associated with 
AMU in this study. The study population is based on a convenience sample 
and cannot be assumed to be a sample entirely representative of British dairy 
farms. There is potential for selection bias, with veterinary practices 
contributing data having previously expressed their interest and proactive 
approach to AMU monitoring, and farms identified via milk recording records 
already being engaged in electronic medicines recording. Despite this, there 
appears to be clear similarities between practices, with most farms in each 
practice representing a relatively low usage of antimicrobials, with a minority 
of farms comprising a major proportion of total AMU (Figs 4 and 5). 
 
FIG 4: Antimicrobial usage (mg/PCU) from sales data to farms (n=292) from four veterinary 
practices and for usage data from farms (n=66) recording medicines usage electronically on 
farm. PCU, population correction unit. 
 
 
FIG 5: Critically important antimicrobial usage (mg/PCU) from sales data to farms (n=292) 
from four veterinary practices and for usage data from farms (n=66) recording medicines 
usage electronically on farm. PCU, population correction unit. 
 
Pressure will no doubt continue to mount on the livestock industry to monitor 
and reduce AMU, and it will be important to monitor AMU at farm level across 
all livestock sectors, employing both mass-based and dose-based metrics. 
This study provides a benchmark for dairy cattle AMU in Britain and identifies 
several factors associated with high AMU. While this study suggests that most 
dairy farms exhibit lower AMU than the UK livestock average, there remains 
an outlying population of farms with high levels of AMU. Identifying high AMU 
farms at a practice or national level will enable AMU reduction efforts to be 
efficiently targeted, and future studies should include the effect of such 
interventions on levels of both AMU and AMR. A proactive veterinary 
approach to herd health management to reduce disease incidence will result 
in fewer antimicrobial treatments being required and will play an important role 
in the reduction of dairy cattle AMU. 
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